• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清脂联素升高与 1 型和 2 型糖尿病患者肾病的相关性及生物标志物潜力:一项荟萃分析。

Association and biomarker potential of elevated serum adiponectin with nephropathy among type 1 and type 2 diabetics: A meta-analysis.

机构信息

Center for Research and Development, Angeles University Foundation, Angeles City, Philippines.

Department of Medical Technology, College of Allied Medical Professions, Angeles University Foundation, Angeles City, Philippines.

出版信息

PLoS One. 2018 Dec 17;13(12):e0208905. doi: 10.1371/journal.pone.0208905. eCollection 2018.

DOI:10.1371/journal.pone.0208905
PMID:30557306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6296550/
Abstract

BACKGROUND

Managing nephropathy associated with diabetes mellitus warrant investigation of relevant biomarkers in predicting this condition. Adiponectin (ADP) may hold promise as a biomarker for diabetic nephropathy (DN). In this study, we examine associations of ADP with DN by meta-analyzing relevant literature. We also examined the predictive potential of ADP and estimate progression of DN.

METHODS

Multi-database literature searches and serial omissions of articles yielded 13 studies for inclusion in the meta-analysis. We compared ADP levels between controls/ normoalbuminuria and cases with micro- and macroalbuminuria (MI and MA, respectively) as well as MI versus MA using standardized mean differences (SMD). Associations of ADP with DN were indicated with the P-value considered significant at ≤ 0.05. Subgrouping was based on diabetes type (1 and 2). Predictive potential of ADP was explored with AUC (area under the curve) derived from Receiver Operating Characteristic curve analysis.

RESULTS AND CONCLUSION

At high P-values of <10-5, overall and subgroup outcomes indicated ADP associations with DN (up to SMD = 1.89-2.26, respectively). However, heterogeneity of the initial SMD effects (up to I2 = 99%) warranted examination of their sources which with the Galbraith plot method, either eliminated or reduced their heterogeneity, signifying combinability of the studies. This feature along with consistency of significant associations, robust outcomes and significant AUC values provide good evidence of the associative and predictive roles of ADP in DN.

摘要

背景

管理与糖尿病相关的肾病需要研究相关的生物标志物来预测这种情况。脂联素(ADP)可能是糖尿病肾病(DN)的生物标志物。在这项研究中,我们通过荟萃分析相关文献来检查 ADP 与 DN 的相关性。我们还检查了 ADP 的预测潜力,并估计了 DN 的进展。

方法

多数据库文献检索和文章的连续遗漏产生了 13 项研究,纳入荟萃分析。我们比较了对照组/正常白蛋白尿和微量白蛋白尿(MI)和大量白蛋白尿(MA)病例之间的 ADP 水平,以及 MI 与 MA 之间的 ADP 水平,使用标准化均数差值(SMD)。当 P 值≤0.05 时,认为 ADP 与 DN 之间存在关联具有统计学意义。亚组分析基于糖尿病类型(1 型和 2 型)。通过接收者操作特征曲线分析得出的 AUC(曲线下面积)来探索 ADP 的预测潜力。

结果和结论

在高 P 值<10-5 的情况下,总体和亚组结果表明 ADP 与 DN 相关(最高 SMD 值为 1.89-2.26)。然而,初始 SMD 效应的异质性(高达 I2 = 99%)需要检查其来源,通过 Galbraith 绘图法,要么消除了它们的异质性,要么降低了它们的异质性,表明这些研究具有可组合性。这一特征以及一致的显著关联、稳健的结果和显著的 AUC 值,为 ADP 在 DN 中的关联和预测作用提供了很好的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b20/6296550/771894a566ba/pone.0208905.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b20/6296550/57a9de5d37b5/pone.0208905.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b20/6296550/364d6c2c5588/pone.0208905.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b20/6296550/68f585a11e1d/pone.0208905.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b20/6296550/0da4ea0188d5/pone.0208905.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b20/6296550/771894a566ba/pone.0208905.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b20/6296550/57a9de5d37b5/pone.0208905.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b20/6296550/364d6c2c5588/pone.0208905.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b20/6296550/68f585a11e1d/pone.0208905.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b20/6296550/0da4ea0188d5/pone.0208905.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b20/6296550/771894a566ba/pone.0208905.g005.jpg

相似文献

1
Association and biomarker potential of elevated serum adiponectin with nephropathy among type 1 and type 2 diabetics: A meta-analysis.血清脂联素升高与 1 型和 2 型糖尿病患者肾病的相关性及生物标志物潜力:一项荟萃分析。
PLoS One. 2018 Dec 17;13(12):e0208905. doi: 10.1371/journal.pone.0208905. eCollection 2018.
2
Serum cystatin C as an early marker of nephropathy among type 2 diabetics: A meta-analysis.血清胱抑素C作为2型糖尿病患者肾病的早期标志物:一项荟萃分析。
Diabetes Metab Syndr. 2019 Nov-Dec;13(6):3093-3097. doi: 10.1016/j.dsx.2019.11.007. Epub 2019 Nov 14.
3
ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.载脂蛋白M/高密度脂蛋白胆固醇(ApoM/HDL-C)和载脂蛋白M/载脂蛋白A-I(apoM/apoA-I)比值是健康对照者和2型糖尿病患者糖尿病肾病的指标。
Clin Chim Acta. 2017 Mar;466:31-37. doi: 10.1016/j.cca.2017.01.006. Epub 2017 Jan 7.
4
Total bilirubin level may be a biomarker of nephropathy in type 2 diabetes mellitus: A meta-analysis of observational studies based on MOOSE compliant.总胆红素水平可能是2型糖尿病肾病的生物标志物:一项基于MOOSE标准的观察性研究的荟萃分析。
Medicine (Baltimore). 2017 Jan;96(1):e5765. doi: 10.1097/MD.0000000000005765.
5
Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.1型糖尿病患者血清脂联素与糖尿病肾病的进展
Diabetes Care. 2008 Jun;31(6):1165-9. doi: 10.2337/dc07-2306. Epub 2008 Mar 17.
6
Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.骨诱导因子是诊断早期糖尿病肾病的一种新型生物标志物。
Int J Clin Exp Pathol. 2015 Mar 1;8(3):3110-5. eCollection 2015.
7
[An association between adiponectin and renal dysfunction in patients with type 2 diabetes mellitus].2型糖尿病患者脂联素与肾功能不全之间的关联
Vnitr Lek. 2012 Nov;58(11):825-9.
8
The potential use of urinary transferrin, urinary adiponectin, urinary Retinol Binding Protein, and serum zinc alpha 2 glycoprotein levels as novel biomarkers for early diagnosis of diabetic nephropathy: A case-control study.尿转铁蛋白、尿脂联素、尿视黄醇结合蛋白和血清锌α2糖蛋白水平在早期诊断糖尿病肾病中的潜在应用:一项病例对照研究。
Diabetes Metab Syndr. 2022 Apr;16(4):102473. doi: 10.1016/j.dsx.2022.102473. Epub 2022 Mar 26.
9
T-cadherin gene variants are associated with nephropathy in subjects with type 1 diabetes.T 钙黏蛋白基因变异与 1 型糖尿病患者的肾病有关。
Nephrol Dial Transplant. 2017 Dec 1;32(12):1987-1993. doi: 10.1093/ndt/gfx071.
10
NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.糖尿病肾病患者中NLRP3表达及尿HSP72与炎症和氧化应激生物标志物的关系
IUBMB Life. 2017 Aug;69(8):623-630. doi: 10.1002/iub.1645. Epub 2017 Jun 20.

引用本文的文献

1
Childhood Obesity: Insight into Kidney Involvement.儿童肥胖症:对肾脏受累的深入了解。
Int J Mol Sci. 2023 Dec 12;24(24):17400. doi: 10.3390/ijms242417400.
2
Serum Adiponectin Level in Different Stages of Type 2 Diabetic Kidney Disease: A Meta-Analysis.血清脂联素水平在 2 型糖尿病肾病不同阶段的变化:一项荟萃分析。
Comput Math Methods Med. 2022 Jul 15;2022:1863243. doi: 10.1155/2022/1863243. eCollection 2022.
3
Obesity and chronic kidney disease: prevalence, mechanism, and management.肥胖与慢性肾脏病:患病率、机制及管理

本文引用的文献

1
Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus.儿童起病系统性红斑狼疮中慢性肾脏损伤和肾功能下降的尿液生物标志物。
Pediatr Nephrol. 2019 Jan;34(1):117-128. doi: 10.1007/s00467-018-4049-5. Epub 2018 Aug 29.
2
The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.脂联素受体激动剂 AdipoRon 改善 2 型糖尿病模型中的糖尿病肾病。
J Am Soc Nephrol. 2018 Apr;29(4):1108-1127. doi: 10.1681/ASN.2017060627. Epub 2018 Jan 12.
3
A study of high-, middle- and low-molecular weight adiponectin in urine as a surrogate marker for early diabetic nephropathy using ultrasensitive immune complex transfer enzyme immunoassay.
Clin Exp Pediatr. 2021 Oct;64(10):511-518. doi: 10.3345/cep.2021.00108. Epub 2021 Apr 6.
4
rs2241766 Gene Polymorphism and Predisposition to Diabetic Kidney Disease.rs2241766 基因多态性与糖尿病肾病易感性。
J Diabetes Res. 2020 Jun 28;2020:5158497. doi: 10.1155/2020/5158497. eCollection 2020.
5
Adiponectin in renal fibrosis.脂联素在肾纤维化中的作用。
Aging (Albany NY). 2020 Feb 17;12(5):4660-4672. doi: 10.18632/aging.102811.
使用超灵敏免疫复合物转移酶免疫测定法,对尿液中高、中、低分子量脂联素作为早期糖尿病肾病替代标志物的研究。
Ann Clin Biochem. 2018 Sep;55(5):525-534. doi: 10.1177/0004563217748681. Epub 2018 Jan 30.
4
Adiponectin and Its Receptors in Diabetic Kidney Disease: Molecular Mechanisms and Clinical Potential.脂联素及其受体在糖尿病肾病中的作用:分子机制与临床应用前景
Endocrinology. 2017 Jul 1;158(7):2022-2034. doi: 10.1210/en.2016-1765.
5
Complication in diabetic nephropathy.糖尿病肾病的并发症。
Diabetes Metab Syndr. 2016 Oct-Dec;10(4):247-249. doi: 10.1016/j.dsx.2016.06.005. Epub 2016 Jun 18.
6
Adiponectin is associated with early diabetic kidney disease in adults with type 1 diabetes: A Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study.脂联素与1型糖尿病成人的早期糖尿病肾病相关:1型糖尿病冠状动脉钙化(CACTI)研究。
J Diabetes Complications. 2017 Feb;31(2):369-374. doi: 10.1016/j.jdiacomp.2016.06.012. Epub 2016 Jun 14.
7
Salivary Glucose as a Diagnostic Marker for Diabetes Mellitus.唾液葡萄糖作为糖尿病的诊断标志物
J Diabetes Sci Technol. 2016 Jul;10(4):991-992. doi: 10.1177/1932296816637619.
8
Association between circulating adipocytokine concentrations and microvascular complications in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of controlled cross-sectional studies.2型糖尿病患者循环脂肪细胞因子浓度与微血管并发症之间的关联:对照横断面研究的系统评价和荟萃分析
J Diabetes Complications. 2016 Mar;30(2):357-67. doi: 10.1016/j.jdiacomp.2015.11.004. Epub 2015 Nov 7.
9
Three simple rules to ensure reasonably credible subgroup analyses.确保亚组分析具有合理可信度的三条简单规则。
BMJ. 2015 Nov 4;351:h5651. doi: 10.1136/bmj.h5651.
10
Urinary adiponectin is an independent predictor of progression to end-stage renal disease in patients with type 1 diabetes and diabetic nephropathy.尿脂联素是 1 型糖尿病合并糖尿病肾病患者进展至终末期肾病的独立预测因子。
Diabetes Care. 2015 May;38(5):883-90. doi: 10.2337/dc14-2276. Epub 2015 Feb 26.